Jing Fan, Min Xu, Ke Liu, Wanping Yan, Huanyu Wu, Hongliang Dong, Yongfeng Yang, Wei Ye
{"title":"IL-15 诱导的 CD38+HLA-DR+CD8+ T 细胞通过 NKG2D 与慢性乙型肝炎肝硬化患者的肝损伤有关","authors":"Jing Fan, Min Xu, Ke Liu, Wanping Yan, Huanyu Wu, Hongliang Dong, Yongfeng Yang, Wei Ye","doi":"10.1002/cti2.70007","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objectives</h3>\n \n <p>CD8<sup>+</sup> T cells play a critical role in the immune dysfunction associated with liver cirrhosis. CD38<sup>+</sup>HLA-DR<sup>+</sup>CD8<sup>+</sup> T cells, or bystander-activated CD8<sup>+</sup> T cells, are involved in tissue injury but their specific contribution to liver cirrhosis remains unclear. This study sought to identify the mechanism for CD38<sup>+</sup>HLA-DR<sup>+</sup>CD8<sup>+</sup> T cell-mediated pathogenesis during liver cirrhosis.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>The immunophenotype, antigen specificity, cytokine secretion and cytotoxicity-related indicators of CD38<sup>+</sup>HLA-DR<sup>+</sup>CD8<sup>+</sup> T cells were determined using flow cytometry. The functional properties of these cells were assessed using transcriptome analysis. CD38<sup>+</sup>HLA-DR<sup>+</sup>CD8<sup>+</sup> T-cell killing was detected using cytotoxicity and antibody-blocking assays.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The proportion of CD38<sup>+</sup>HLA-DR<sup>+</sup>CD8<sup>+</sup> T cells was significantly elevated in liver cirrhosis patients and correlated with tissue damage. Transcriptome analysis revealed that these cells had innate-like functional characteristics. This CD8<sup>+</sup> T-cell population primarily consisted of effector memory T cells and produced a high level of cytotoxicity-related cytokines, granzyme B and perforin. IL-15 promoted CD38<sup>+</sup>HLA-DR<sup>+</sup>CD8<sup>+</sup> T-cell activation and proliferation, inducing significant TCR-independent cytotoxicity mediated through NKG2D.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>CD38<sup>+</sup>HLA-DR<sup>+</sup>CD8<sup>+</sup> T cells correlated with cirrhosis-related liver injury and contributed to liver damage by signalling through NKG2D in a TCR-independent manner.</p>\n </section>\n </div>","PeriodicalId":152,"journal":{"name":"Clinical & Translational Immunology","volume":"13 10","pages":""},"PeriodicalIF":4.6000,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cti2.70007","citationCount":"0","resultStr":"{\"title\":\"IL-15-induced CD38+HLA-DR+CD8+ T cells correlate with liver injury via NKG2D in chronic hepatitis B cirrhosis\",\"authors\":\"Jing Fan, Min Xu, Ke Liu, Wanping Yan, Huanyu Wu, Hongliang Dong, Yongfeng Yang, Wei Ye\",\"doi\":\"10.1002/cti2.70007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Objectives</h3>\\n \\n <p>CD8<sup>+</sup> T cells play a critical role in the immune dysfunction associated with liver cirrhosis. CD38<sup>+</sup>HLA-DR<sup>+</sup>CD8<sup>+</sup> T cells, or bystander-activated CD8<sup>+</sup> T cells, are involved in tissue injury but their specific contribution to liver cirrhosis remains unclear. This study sought to identify the mechanism for CD38<sup>+</sup>HLA-DR<sup>+</sup>CD8<sup>+</sup> T cell-mediated pathogenesis during liver cirrhosis.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>The immunophenotype, antigen specificity, cytokine secretion and cytotoxicity-related indicators of CD38<sup>+</sup>HLA-DR<sup>+</sup>CD8<sup>+</sup> T cells were determined using flow cytometry. The functional properties of these cells were assessed using transcriptome analysis. CD38<sup>+</sup>HLA-DR<sup>+</sup>CD8<sup>+</sup> T-cell killing was detected using cytotoxicity and antibody-blocking assays.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>The proportion of CD38<sup>+</sup>HLA-DR<sup>+</sup>CD8<sup>+</sup> T cells was significantly elevated in liver cirrhosis patients and correlated with tissue damage. Transcriptome analysis revealed that these cells had innate-like functional characteristics. This CD8<sup>+</sup> T-cell population primarily consisted of effector memory T cells and produced a high level of cytotoxicity-related cytokines, granzyme B and perforin. IL-15 promoted CD38<sup>+</sup>HLA-DR<sup>+</sup>CD8<sup>+</sup> T-cell activation and proliferation, inducing significant TCR-independent cytotoxicity mediated through NKG2D.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>CD38<sup>+</sup>HLA-DR<sup>+</sup>CD8<sup>+</sup> T cells correlated with cirrhosis-related liver injury and contributed to liver damage by signalling through NKG2D in a TCR-independent manner.</p>\\n </section>\\n </div>\",\"PeriodicalId\":152,\"journal\":{\"name\":\"Clinical & Translational Immunology\",\"volume\":\"13 10\",\"pages\":\"\"},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2024-10-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cti2.70007\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical & Translational Immunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cti2.70007\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Translational Immunology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cti2.70007","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的 CD8+ T细胞在与肝硬化相关的免疫功能失调中起着关键作用。CD38+HLA-DR+CD8+ T细胞或旁观者激活的CD8+ T细胞参与组织损伤,但它们对肝硬化的具体贡献仍不清楚。本研究试图确定 CD38+HLA-DR+CD8+ T 细胞介导的肝硬化发病机制。 方法 使用流式细胞术测定 CD38+HLA-DR+CD8+ T 细胞的免疫表型、抗原特异性、细胞因子分泌和细胞毒性相关指标。转录组分析评估了这些细胞的功能特性。CD38+HLA-DR+CD8+T细胞的杀伤力是通过细胞毒性和抗体阻断试验检测的。 结果 肝硬化患者 CD38+HLA-DR+CD8+ T 细胞的比例明显升高,并与组织损伤相关。转录组分析表明,这些细胞具有类似先天性的功能特征。这种CD8+ T细胞群主要由效应记忆T细胞组成,能产生大量细胞毒性相关细胞因子、颗粒酶B和穿孔素。IL-15 促进了 CD38+HLA-DR+CD8+ T 细胞的活化和增殖,并通过 NKG2D 诱导了显著的 TCR 依赖性细胞毒性。 结论 CD38+HLA-DR+CD8+ T细胞与肝硬化相关的肝损伤有关,并通过NKG2D以一种TCR无关的方式发出信号,导致肝损伤。
IL-15-induced CD38+HLA-DR+CD8+ T cells correlate with liver injury via NKG2D in chronic hepatitis B cirrhosis
Objectives
CD8+ T cells play a critical role in the immune dysfunction associated with liver cirrhosis. CD38+HLA-DR+CD8+ T cells, or bystander-activated CD8+ T cells, are involved in tissue injury but their specific contribution to liver cirrhosis remains unclear. This study sought to identify the mechanism for CD38+HLA-DR+CD8+ T cell-mediated pathogenesis during liver cirrhosis.
Methods
The immunophenotype, antigen specificity, cytokine secretion and cytotoxicity-related indicators of CD38+HLA-DR+CD8+ T cells were determined using flow cytometry. The functional properties of these cells were assessed using transcriptome analysis. CD38+HLA-DR+CD8+ T-cell killing was detected using cytotoxicity and antibody-blocking assays.
Results
The proportion of CD38+HLA-DR+CD8+ T cells was significantly elevated in liver cirrhosis patients and correlated with tissue damage. Transcriptome analysis revealed that these cells had innate-like functional characteristics. This CD8+ T-cell population primarily consisted of effector memory T cells and produced a high level of cytotoxicity-related cytokines, granzyme B and perforin. IL-15 promoted CD38+HLA-DR+CD8+ T-cell activation and proliferation, inducing significant TCR-independent cytotoxicity mediated through NKG2D.
Conclusions
CD38+HLA-DR+CD8+ T cells correlated with cirrhosis-related liver injury and contributed to liver damage by signalling through NKG2D in a TCR-independent manner.
期刊介绍:
Clinical & Translational Immunology is an open access, fully peer-reviewed journal devoted to publishing cutting-edge advances in biomedical research for scientists and physicians. The Journal covers fields including cancer biology, cardiovascular research, gene therapy, immunology, vaccine development and disease pathogenesis and therapy at the earliest phases of investigation.